<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01314209</url>
  </required_header>
  <id_info>
    <org_study_id>11102010</org_study_id>
    <nct_id>NCT01314209</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)</brief_title>
  <official_title>Dexmedetomidine Pharmacokinetics During Continuous Venovenous Hemodialysis in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine dexmedetomidine pharmacokinetics during continuous
      renal replacement therapy on critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dexmedetomidine is a selective alpha-2-adrenergic agonist with sedative properties indicated
      for sedation of patients in the intensive care setting. ICU patients with acute kidney injury
      requiring renal replacement therapies frequently have changes in volume status causing
      alterations in drug pharmacokinetics. Although dexmedetomidine pharmacokinetics have been
      studied earlier on ICU patients, there is no information on its pharmacokinetics in
      critically ill patients needing continuous renal replacement therapy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dexmedetomidine clearance by continuous venovenous hemodialysis</measure>
    <time_frame>10 hours from the start of the dexmedetomidine infusion</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine 0.7 microg/kg/h 12-hour intravenous infusion</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18

          -  Clinical need for sedation

          -  Acute kidney injury requiring renal replacement therapy (according to ICUs standard
             operating procedures)

        Exclusion Criteria:

          -  Severe bradycardia (HR &lt; 50/min)

          -  AV conduction block II-III (unless pacemaker installed)

          -  Severe hepatic impairment (bilirubin &gt; 101 umol/l)

          -  Pregnancy or lactation

          -  Age &lt; 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirsi-Maija Kaukonen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, HUCH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kirsi-Maija Kaukonen, MD, PhD</last_name>
    <phone>+358 50 4271059</phone>
    <email>maija.kaukonen@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Suvi Vaara, MD</last_name>
    <phone>+358 50 3312433</phone>
    <email>suvi.vaara@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meilahti Hospital, Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsi-Maija Kaukonen, MD, PhD</last_name>
      <phone>+358 504271059</phone>
      <email>maija.kaukonen@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Suvi Vaara, MD</last_name>
      <phone>+358 503312433</phone>
      <email>suvi.vaara@hus.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2011</study_first_submitted>
  <study_first_submitted_qc>March 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2011</study_first_posted>
  <last_update_submitted>October 23, 2012</last_update_submitted>
  <last_update_submitted_qc>October 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 24, 2012</last_update_posted>
  <responsible_party>
    <name_title>Kirsi-Maija Kaukonen</name_title>
    <organization>Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, Helsinki University Central Hospital</organization>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>critical illness</keyword>
  <keyword>continuous renal replacement therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

